Is Mediastinoscopy Still the Gold Standard to Evaluate Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma?

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Objectives In this study, we aimed to define the efficacy of F-18 FDG PET/CT for the detection of mediastinal lymph node metastases by comparing the mediastinal findings of F-18 FDG PET/CT with the histopathological results obtained either by mediastinoscopy or thoracotomy in patients with clinically operable non-small cell lung cancer (NSCLC).

Material and Methods This is a prospective, single-institution study of 68 consecutive patients with suspected or pathologically proven, localized, clinically resectable NSCLC (8 females and 60 males; mean age: 60.36 ±  1.01 years, range: 43–78 years). The patients underwent integrated PET/CT scanning at the same PET center. Standard cervical mediastinoscopy and extended mediastinoscopy were performed to sample the lymph nodes. During thoracotomy, complete mediastinal lymph node dissection was routinely performed.

Results Mediastinoscopy gave true positive results in 9 patients and true negative results in 57 patients. There were two false negative results. Mediastinoscopy had a sensitivity of 81.8% (95% CI: 63–82), a specificity of 100% (95% CI: 96–100), a PPV of 100% (95% CI: 77–100), a NPV of 96.6% (95% CI: 93–96), and an accuracy of 97% for the detection of mediastinal lymph node metastases. When PET/CT results were compared with postoperative pathological examination results, PET/CT correctly identified 48 out of 50 patients (96%) who did not have metastatic lymph node involvement. N2/N3 disease was correctly determined by PET/CT in 8 of 11 patients (72.7%) who had positive results on histological analysis. When only N2 and N3 nodal diseases were included in the calculation with the aim of making a comparison with mediastinoscopy (for mediastinal nodes), integrated PET/CT had a sensitivity of 72.7% (95% CI: 51–80), a specificity of 97.7% (95% CI: 92–99), a PPV of 88.9% (95% CI: 62–97), a NPV of 93.3% (95% CI: 88–95) and an accuracy of 92.6% (95% 83–95) for the detection of intrathoracic N2 and N3 nodal metastases.

Conclusion Our data shows that due to its high sensitivity and accuracy, mediastinoscopy is still the most reliable method to evaluate mediastinal lymph nodes in patients with NSCLC.

• References

• 1 De Leyn P, Lardinois D, Van Schil PE , et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007; 32: 1-8
  CrossrefPubMedGoogle Scholar
• 2 Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s – meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-536
  PubMedGoogle Scholar
• 3 Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 137-146
  CrossrefPubMedGoogle Scholar
• 4 De Leyn P, Vansteenkiste J, Cuypers P , et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997; 12: 706-712
  CrossrefPubMedGoogle Scholar
• 5 Prévost A, Papathanassiou D, Jovenin N , et al. Comparison between FDG PET and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients. Rev Pneumol Clin 2009; 65: 341-349
  CrossrefPubMedGoogle Scholar
• 6 Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY. Revisiting the prognostic value of preoperative (18) F-fluoro-2-deoxyglucose (18) F-FDG positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). Eur J Nucl Med Mol Imaging 2010; 37: 691-698
  CrossrefPubMedGoogle Scholar
• 7 Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography. Imaging in the staging of patients with suspected lung cancer. Chest 2004; 125: 2300-2308
  CrossrefPubMedGoogle Scholar
• 8 Birim O, Kappetein AP, Stijnen T, Bogers AJ. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 2005; 79: 375-382
  CrossrefPubMedGoogle Scholar
• 9 Li XD, Yin JL, Liu WK , et al. Value of positron emission tomography-computed tomography in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30: 506-508
  PubMedGoogle Scholar
• 10 Billé A, Pelosi E, Skanjeti A , et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 2009; 36: 440-445
  CrossrefPubMedGoogle Scholar
• 11 Ventura E, Islam T, Gee MS, Mahmood U, Braschi M, Harisinghani MG. Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT. Clin Imaging 2010; 34: 20-28
  CrossrefPubMedGoogle Scholar
• 12 Hürtgen M, Friedel G, Tomes H, Fritz P. Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA)-technique and first results. Eur J Cardiothorac Surg 2002; 21: 348-351
  CrossrefPubMedGoogle Scholar
• 13 Kuzdzal J, Zielinski M, Papla B , et al. Transcervical extended mediastinal lymphadenectomy – the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 2005; 27: 384-390
  CrossrefPubMedGoogle Scholar
• 14 Mountain CF, Dressler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723
  CrossrefPubMedGoogle Scholar
• 15 Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J. Silvestri GA. American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 202-220
  CrossrefPubMedGoogle Scholar
• 16 Smulders SA, Smeenk FWJW, Janssen-Heijnen MLG, Wielders PLML, de Munck DRAJ, Postmus PE. Surgical mediastinal staging in daily practice. Lung Cancer 2005; 47: 243-251
  CrossrefPubMedGoogle Scholar
• 17 Kuzdzal J, Zielinski M, Papla B , et al. Transcervical extended mediastinal lymphadenectomy. The new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 2005; 27: 384-390
  CrossrefPubMedGoogle Scholar
• 18 Witte B, Hürtgen M. Video-assisted mediastinoscopic lymphadenectomy (VAMLA). J Thorac Oncol 2007; 2 (4) 367-369
  CrossrefPubMedGoogle Scholar
• 19 Kim BT, Lee KS, Shim SS , et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT – a prospective study. Radiology 2006; 241: 501-509
  CrossrefPubMedGoogle Scholar
• 20 Yi CA, Lee KS, Kim BT , et al. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR 2007; 188: 318-325
  CrossrefPubMedGoogle Scholar
• 21 Shim SS, Lee KS, Kim BT , et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-1019
  CrossrefPubMedGoogle Scholar
• 22 Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Toraks 2007; 62: 696-701
  PubMedGoogle Scholar
• 23 Roberts PF, Follette DM, von Haag D , et al. Factors associated with false positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70: 1154-1159
  CrossrefPubMedGoogle Scholar
• 24 Gonzalez-Stawinski GV, Lemaire A, Merchant F , et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126: 1900-1905
  CrossrefPubMedGoogle Scholar